← Back to Search

Thermal Ablation

NanoTherm Ablation for Prostate Cancer

N/A

Waitlist Available

Research Sponsored by MagForce USA

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 months (+/- 1 month)

Awards & highlights

Study Summary

This trial is testing a new way to treat prostate cancer that uses heat. They will test to see if it is effective by doing a biopsy 4 months after the treatment.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 months (+/- 1 month)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 months (+/- 1 month)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months (+/- 1 month) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of Ablation Success

Secondary outcome measures

Adverse Event Rate

Trial Design

1Treatment groups

Experimental Treatment

Group I: Ablation ArmExperimental Treatment1 Intervention

Subjects in this arm of the study will have focal ablation of the prostate cancer lesion with the NanoTherm technology. This ablation will be followed-up transperineal prostate biopsy at 4 months after treatment.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

MagForce USALead Sponsor

1 Previous Clinical Trials

100 Total Patients Enrolled

David Hammond, MSStudy DirectorMagForce USA

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any open enrollment opportunities for this clinical investigation?

"Affirmative. According to clinicaltrials.gov, the research project - which was initially announced on November 30th 2021 - is actively seeking candidates. In total, they are looking for 30 volunteers across 5 distinct sites of enrolment."

Answered by AI

Would I meet the eligibility criteria to participate in this trial?

"This medical study is admitting 30 participants who meet the inclusion criteria of having prostate cancer, and being between 40-85 years old."

Answered by AI

How many physical sites are overseeing this experiment's execution?

"This study is being administered in 5 distinct locations, including Urology Austin in Austin, Florida Urology Partners in Tampa, and MagForce - San Antonio in Seattle. Additionally, there are 2 more sites listed on the clinical trial page."

Answered by AI

How many participants is this clinical trial recruiting?

"The sponsor, MagForce USA, needs to enrol 30 fitting candidates for the trial. This will be done through two distinct sites - Urology Austin in Texas and Florida Urology Partners in Tampa, Washington."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer

2021. "Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05010759.